Here in this study, we showed that PHF6 played a pro-oncogenic role in myeloid leukemia development induced by RUNX1-ETO9a and MLL-AF9 in mice, while PHF6 is not essential for normal hematopoiesis, suggesting it might be an attractive drug target. Here, KMT2A is linked to myeloid leukemia.